Abstract
Lipid-based drug delivery has been an ever-growing field of research these last few decades right from its inception as fat emulsion(s) for parenteral nutrition in the past to the present day targeted delivery of drugs. Lipid-based nanosystems constitute liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and self-nanoemulsifying drug delivery systems (SNEDDS). Use of lipids for improving the bioavailability and solubility of drugs and advantages like biocompatibility, lesser susceptibility to erosion phenomena, and slower water uptake makes them the ideal choice for delivering therapeutics in a controlled and targeted manner. Present chapter comprehensively covers the available lipids and excipients including emulsifiers used in the preparation of these lipid nanoparticle their method of preparation and factors affecting their performance characteristics. Also included are the major characterization parameters, pharmacokinetic behavior, and ways to improve bioperformance and targetability of these nanomaterials. Safety issues and specialized application in gene delivery are also touched upon in the end.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Desai PP, Date AA, Patravale VB (2012) Overcoming poor oral bioavailability using nanoparticle formulations: opportunities and limitations. Drug Discov Today Technol 9:e87–e95
Bhandari R, Kaur IP (2013) Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm 441:202–212
Xue M, Zhao Y, Li X-j, Jiang Z-z, Zhang L, Liu S-h, Li X-m, Zhang L-Y, Yang S-y (2012) Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Eur J Pharm Biopharm 47:713–717
Qi J, Lu Y, Wu W (2012) Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. Curr Drug Metab 13:418–428
Singh H, Bhandari R, Kaur IP (2013) Encapsulation of rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with isoniazid at acidic pH. Int J Pharm 446:106–111
Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP (2009) Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 5:184–191
Sanjula B, Shah FM, Javed A, Alka A (2009) Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target 17:249–256
Olivier JC (2005) Drug transport to brain with targeted nanoparticles. NeuroRx 2:108–119
Tabatt K, Kneuer C, Sameti M, Olbrich C, Müller RH, Lehr CM, Bakowsky U (2004) Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes. J Control Release 97:321–332
Trevaskis NL, Charman WN, Porter CJ (2008) Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 60:702–716
Dong X, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ (2009) Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-Glycoprotein and depleting ATP. Cancer Res 69:3918–3926
Chabra S, Ranjan M, Bhandari R, Kaur T, Aggrawal M, Puri V, Mahajan N, Kaur IP, Puri S, Sobti RC (2011) Solid lipid nanoparticles regulate functional assortment of mouse mesenchymal stem cells. J Stem Cells Regen Med 7:75–79
Hu C-MJ, Zhang L (2012) Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol 83:1104–1111
Lucks JS, Müller RH, Konig B (1992) Solid lipid nanoparticles (SLN) – an alternative parenteral drug carrier system. Eur J Pharm Biopharm 38:33S
Kang KC, Lee CI, Pyo HB, Jeong NH (2005) Preparation and characterization of nano-liposomes using phosphatidylcholine. J Ind Eng Chem 11:847–851
Schwarz C, Mehnert W, Lucks JS, Muller RH (1994) Solid lipid nanoparticles for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 30:83–96
Lee GS, Lee DH, Kang KC, Lee CI, Pyo HB, Choi TB (2007) Preparation and characterization of bis-ethylhexyloxyphenolmethoxyphenyltriazine (BEMT) loaded solid lipid nano-particles (SLN). J Ind Eng Chem 13:1180–1187
Yang HJ, Cho WG, Park SN (2009) Stability of oil-in-water emulsions prepared using the phase inversion composition method. J Ind Eng Chem 15:331
Kaur IP, Bhandari R, Bhandari S, Kakkar V (2008) Potential of solid lipid nanoparticles in brain targeting. J Control Release 127:97–109
Jenning V, Lippacher A, Gohla SH (2002) Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization. J Microencapsul 19:1–10
Cavalli R, Caputo O, Gasco MR (2000) Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur J Pharm Biopharm 10:305–330
Almeida AJ, Runge S, Miiller RH (1997) Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 149:255–265
Rawat M, Manju S, Singh D, Saraf S (2008) Lipid carriers: a versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi 128:269–280
Westesen K, Bunjas H, Koch MHJ (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48:223–236
Hu L, Tang X, Cui F (2004) Solid lipid Nanoparticles. (SLNs) to improve oral bioavailability of poorly soluble drug. J Pharm Pharmacol 56:1527–1535
Lim S, Lee M, Kim C (2004) Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 100:53–61
Kakkar V, Singh S, Singla D, Kaur IP (2011) Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 55:495–503
Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, Severin SE, Uhl R, Kock M, Geiger KD, Gelperina SE (2004) Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 109:759–767
Bhandari R, Kaur IP (2013) A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. Curr Nanosci 9:211–220
Lim SB, Banerjee A, Onyukel H (2012) Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release 163:34–45
Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, Rahimi AA (2012) Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm 424:128–137
Radtke M, Souto EB, Muller R (2005) Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Technol Eur 17:45–50
Muchow M, Maincent P, Müller RH (2008) Lipid nanoparticles with a solid matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery. Drug Dev Ind Pharm 34:1394–1405
Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J (2012) Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target 20:813–830
Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ (2008) Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers. Curr Drug Deliv 5:324–331
Kuo YC, Chung JF (2011) Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf B Biointerfaces 83:299–306
Villar AMS, Naveros BC, Campmany ACC, Trenchs MAZ, Rocabert CB, Bellowa LH (2012) Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm 431:161–175
Constantinides PP (1995) Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 12:1561–1572
Zhao Y, Wang C, Chow AHL, Ren K, Gong T, Zhang Z, Zheng Y (2010) Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int J Pharm 383:170–177
Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z (2010) Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm 383:1–6
Basalious EB, Shawky N, Badr-Eldin SM (2010) SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 391:203–211
Larsen AT, Ogbonna A, Abu-Rmaileh R, Abrahamsson B, Østergaard J, Müllertz A (2012) SNEDDS containing poorly water soluble cinnarizine; development and in vitro characterization of dispersion, digestion and solubilization. Pharmaceutics 4:641–665
Shah NH, Carvajal MT, Patel CI, Infield MH, Malick AW (1994) Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 106:15–23
Pouton CW (1985) Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 27:335–348
Gershanik T, Benita S (2000) Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 50:179–188
Kommuru TR, Gurley B, Khan MA, Reddy IK (2001) Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212:233–246
Chakraborty S, Shukla D, Mishra B, Singh S (2009) Lipid-an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm 73:1–15
Patil PR, Biradar SV, Paradkar AR (2009) Extended release felodipine self-nanoemulsifying system. AAPS PharmSciTech 10:515–523
Nazzal S, Khan MA (2006) Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm 315:110–121
Shanmugam S, Baskaran R, Balakrishnan P, Thapa P, Yong CS, Yoo BK (2011) Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur J Pharm Biopharm 79:250–257
Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA (2002) Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm 235:247–265
Nielsen FS, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen JS, Müllertz A (2007) Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J Pharm Sci 96:876–892
Nepal PR, Han HK, Choi HK (2010) Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur J Pharm Sci 39:224–232
Nielsen FS, Petersen KB, Müllertz A (2008) Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm 69:553–562
Date AA, Desai N, Dixit R, Nagarsenker M (2010) Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond) 5:1595–1616
Grubber SM (1987) Liposomes: from biophysics to therapeutics. Marc Ostro (Ed.). Marcel Dekker: New York
Samad A, Sultana Y, Aqil M (2007) Liposomal drug delivery systems: an update review. Curr Drug Deliv 4:297–305
Johnston APR, Such GK, Ng SL, Caruso F (2011) Challenges facing colloidal delivery systems: from synthesis to the clinic. Curr Opin Colloid Interface Sci 16:171–181
Lee JS, Ankone M, Pieters E, Schiffelers RM, Hennink WE, Feijen J (2011) Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes. J Control Release 155:282–288
Crommelin DJA, Daemen T, Scherphof GL, Vingerhoeds MH, Heeremans JLM, Kluft C, Storm G (1997) Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins. J Control Release 46:165–175
Gabizon A, Goren D, Horowitz AT, Tzemach D, Lossos A, Siegal T (1997) Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv Drug Deliv Rev 24:337–344
Sharma A, Sharma US (1997) Liposomes in drug delivery: progress and limitations. Int J Pharm 154:123–140
Aggarwal D, Kaur IP (2005) Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 290:155–159
Cortesi R, Esposito E, Luca G, Nastruzzi C (2002) Production of lipospheres as carriers for bioactive compounds. Biomaterials 23:2283–2294
Olbrich C, Gessner A, Schröder W, Kayser O, Müller RH (2004) Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. J Control Release 96:425–435
Jie L, Tao G, Changguang W, Zhirong Z, Zhirong Z (2007) Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 340:153–162
Morel S, Ugazio E, Cavalli R, Gasco MR (1996) Thymopentin in solid lipid nanoparticles. Int J Pharm 132:259–261
Reithmeier H, Herrmann J, Gopferich A (2001) Lipid microparticles as a parenteral controlled release device for peptides. J Control Release 73:339–350
Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S (2010) Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull 58:650–655
Nair R, Priya KV, Kumar KS, Badivaddin TM, Sevukarajan M (2011) Formulation and evaluation of solid lipid nanoparticles of water soluble drug: isoniazid. Int J Pharm Pharm Sci 3:1256–1264
Stancampiano AHS, Puglisi G, Pignatello R (2008) Effect of lipophilicity of dispersed drugs on the physicochemical and technological properties of solid lipid nanoparticles. Open Drug Deliv J 2:26–32
Singh S, Dobhal AK, Jain A, Pandit PK, Chakarborty S (2010) Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull (Tokyo) 58:650–655
Kuo YC, Liang CT (2011) Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells. Colloids Surf B Biointerfaces 85:131–137
Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X (2007) Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 328:191–195
Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16
Ugazio E, Marengo E, Pellizzaro C, Coradini D, Peira E, Daidone MG, Gasco MR (2001) The effect of formulation and concentration of cholesteryl butyrate solid lipid nanospheres (SLN) on NIH-H460 cell proliferation. Eur J Pharm Biopharm 52:197–202
Mahon E, Salvati A, Baldelli BF, Lynch I, Dawson KA (2012) Designing the nanoparticle-biomolecule interface for “targeting and therapeutic delivery”. J Control Release 161:164–174
Martins S, Tho I, Ferreira DC, Souto EB, Brandl M (2011) Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition. Drug Dev Ind Pharm 37:815–824
Risovic V, Boyd M, Choo E, Wasan KM (2003) Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats. Antimicrob Agents Chemother 47:3339–3342
Muhlen AZ, Schwarz C, Mehnert W (1998) Solid lipid nanoparticles for controlled drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 45:149–155
Bhandari R, Kaur IP (2012) A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. Curr Nanosci 9:211–220
Vitorino C, Carvalho FA, Almeida AJ, Sousa JJ, Pais AACC (2011) The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces 84:117–130
Chen LT, Weiss L (1973) The role of the sinus wall in the passage of erythrocytes through the spleen. Blood 41:529–537
Moghimi SM, Porter CJH, Muir IS, Illum L, Davis SS (1991) Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 177:861–866
Drenckhahn D, Wagner J (1986) Stress fibers in the splenic sinus endothelium in situ: molecular structure, relationship to the extracellular matrix and contradictibility. J Cell Biol 102:1738–1747
Groom AC (1987) Microcirculation of the spleen: new concepts. Microvasc Res 34:269–289
Moghimi SM, Hunter C, Murray JC (2001) Long-circulating and target-specific nanoparticles:theory to practice. Pharmacol Rev 53:283–318
Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 105:11613–11618
Qiu Y, Liu Y, Wang LM, Xu LG, Bai R (2010) Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31:7606–7619
Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668
Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A 102:9469–9474
Yuan HY, Li J, Bao G, Zhang SL (2010) Variable nanoparticle-cell adhesion strength regulates cellular uptake. Phys Rev Lett 105:1381011–1381014
Chithrani BD, Chan WC (2007) Elucidating the mechanism of cellular uptake and removal of protein coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542–1550
Lu F, Wu SH, Hung Y, Mou CY (2009) Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5:1408–1413
Jin H, Heller DA, Sharma R, Strano MS (2009) Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 3:149–158
Fahy E, Cotter D, Sud M, Subramaniam S (2011) Lipid classification, structures and tools. Biochim Biophys Acta 1811:637–647
Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214–221
Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ (2004) Comparison of cell uptake, biodistribution and tumor retention of folate coated and PEG coated gadolinium nanoparticles in tumor bearing mice. J Control Release 95:613–626
Goppert TM, Muller RH (2005) Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain. Comparison of plasma protein adsorption patterns. J Drug Target 13:179–187
Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S (2009) Size-dependent endocytosis of nanoparticles. Adv Mater 21:419–424
Panyam J, Labhasetwar V (2003) Dynamics of endocytosis and exocytosis of poly(D, L-Lactide-co-Glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20:212–220
Kakkar V, Mishra AK, Chuttani K, Chopra K, Kaur IP (2011) Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements. Rejuvenation Res 14:597–604
Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J (2006) Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effects of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul 23:582–592
Iea B (2004) Negative preclinical results with stealth1 nanospheres encapsulated doxorubicin in an orthotopic murine brain tumor model. J Control Release 100:29–40
Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J (1997) Delivery of loperamide across the blood brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res 14:325–328
Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients, 6th edn. Pharmaceutical Press, Greyslake
Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Büchel C, Briesen HV, Kreuter J (2009) Albumin nanoparticles targeted with apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release 137:78–86
Koziara JM, Lockman PR, Allen DD, Mumper RJ (2003) In situ blood-brain barrier transport of nanoparticles. Pharm Res 20:1772–1778
www.mfc.co.jp downloaded from http://www.mfc.co.jp/english/productinfor.htm. Accessed 4 Apr 2013
Pasquali RC, Bregni C, Taurozzi MP (2009) New values of the required hydrophilic-lipophilic balance for oil in water emulsions of solid fatty acids and alcohols obtained from solubility parameter and dielectric constant values. J Dispers Sci Technol 30:328–331
HSDB (2013) Downloaded from http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/∼10IcEv:1. Accessed 23 Feb 2013
Michael Ash IA (2007) Handbook of fillers, extenders, and diluents, 2nd edn. Synapse Information Resources, Endicott
Gattefossé (2013) Technical documents accessed from http://www.gattefosse.com/en/document-center/. Accessed 17 Feb 2013
www.sasoltechdata.com. Downloaded from www.sasoltechdata.com/…/Excipients_Pharmaceuticals.pdf. Accessed 9 Apr 2013
www.sasoltechdata.com/…/Excipients_Pharmaceuticals.pdf. Downloaded from www.sasoltechdata.com/…/Excipients_Pharmaceuticals.pdf. Accessed 9 Apr 2013
www.ntp.niehs.nih.gov. Downloaded from http://ntp.niehs.nih.gov/index.cfm?objectid=E8841408-BDB5-82F8-FC7F7D3E0F941C7E. Accessed 2nd Jan 2013
Severino P, Andreani T, SofiaMacedo A, Fangueiro JF, Santana MA, Silva AM, Souto EB (2012) Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv. doi:10.1155/2012/750891
Trotta M, Debernardi F, Caputo O (2003) Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 257:153–160
www.sigmaaldrich.com. Detergents properties and applications. Downloaded from www.sigmaaldrich.com/img/assets/…/Detergent_Selection_Table.pdf. Accessed 3 Jan 2013
Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS (2006) Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 62:155–162
Heiati H, Tawashi R, Phillips NC (1998) Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J Microencapsul 15:173–184
Bunjes H, Westesen K, Koch MHJ (1996) Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 129:159–173
Cavalli R, Gasco MR, Morel S (1992) Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters. STP Pharma Sci 2:514–518
Mehnert W, Mader K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–196
Siekmann B, Westesen K (1992) Submicron-sized parenteral carrier systems based on solid lipids. Pharm Pharmacol Lett 1:123–126
Thassu D, Pathak Y, Deleers M (2007) Nanoparticulate drug delivery systems: an overview in nanoparticulate drug delivery systems. Informa Healthcare, New York, pp 1–31
Wissing SA, Kayser O, Müller RH (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Del Rev 56:1257–1272
Sjostrom B, Bergenstahl B (1992) Preparation of submicron drug particles in lecithin-stabilized o/w emulsions: I: Model studies of the precipitation of cholesteryl acetate. Int J Pharm 88:53–62
Siekmann B, Westesen K (1996) Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur J Pharm Biopharm 43:104–109
Gasco MR (1993) Method for producing solid lipid microspheres having a narrow size distribution. US Patent 5250236
Muller RH (1990) Colloidal carriers for controlled drug delivery and targeting. Verlagsgesellschaft GmbH, Stuttgart
Cavalli R, Caputo O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR (1997) Sterilization and freeze drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm 148:47–54
Gasco MR (1997) Solid lipid nanospheres from warm micro-emulsions. Pharm Technol Eur 9:52–58
Boltri L, Canal T, Esposito PA, Carli F (1993) Evaluation of some critical formulation parameters: lipid nanoparticles. Proc Intern Symp Control Rel Bioact Mater 20:346–347
Kaur IP, Bhandari R (2012) Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and a process for preparing the same. PCT application number: PCT/IN2012/000154 dated 5 March 2012
Kaur IP, Bhandari R (2012) Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and a process for preparing the same. Indian patent application number: 127/DEL/2012, dated 13 Jan 2012
Kaur IP, Verma MK (2012) Solid nanolipidic particulates of retinoic acid and vitamin D3 with DCGI. Indian patent application number: 79/DEL/2012 dated 9 Jan 2012
Kaur IP, Singh M, Verma MK (2012) Oral nanocolloidal aqueous dispersion (NCD) of streptomycin sulfate. Indian patent application number: 3093/DEL/2012, dated 3 Jan 2012
Kaur IP, Verma MK (2013) A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins. PCT application number: PCT/IB2013/050169, dated 9 Jan 2013
Das S, Chaudhury A (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 12:62–76
Kaiser CS, Rompp H, Schmidt PC (2001) Pharmaceutical applications of supercritical carbon dioxide. Pharmazie 56:907–926
Chen YJ, Jin RX, Zhou YQ, Zeng J, Zhang H, Feng QR (2006) Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release. Zhongguo Zhong Yao Za Zhi 31:376–379
Freitas C, Muller RH (1998) Spray-drying of Solid lipid nanoparticles (SLN TM). Eur J Pharm Biopharm 46:145–151
Charcosset C, El-Harati A, Fessi H (2005) Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 108:112–120
Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD (2003) Brain uptake of thiamine-coated nanoparticles. J Control Release 93:271–282
Manjunath K, Reddy JS, Venkateswarlu V (2005) Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol 27:127–144
Thassu D, Pathak Y, Deleers M (2007) Nanoparticulate drug delivery systems: nanoengineering of drug delivery systems. Informa Healthcare, New York, pp 99–109
Cook RO, Pannu RK, Kellaway IW (2005) Novel sustained release microspheres for pulmonary drug delivery. J Control Release 104:79–90
Westesen K, Siekmann B, Koch MHJ (1993) Investigations on the physical state of lipid nanoparticles by synchrotron X-ray diffraction. Int J Pharm 93:189–199
Guo X, Xing Y, Zhang X, Li J, Mei Q, Zhang H, Chen C, Zhang Z, Cui F (2012) In vivo controlled release and prolonged antitumor effects of 2-methoxyestradiol solid lipid nanoparticles incorporated into a thermosensitive hydrogel. Drug Deliv 19:188–193
Guo X, Cui F, Xing Y, Mei Q, Zhang Z (2011) Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles. Pharmazie 66:948–952
Muller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–177
zur Muhlen A, Schwarz C, Mehnert W (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 45:149–155
Muller RH, Mehnert W, Lucks JS, Schwarz C, Muhlen AZ, Weyhers H, Freitas C, Ruhl D (1995) Solid lipid nanoparticles (SLN) – an alternative colloidal carrier systems for controlled drug delivery. Eur J Pharm Biopharm 41:62–69
Pardridge WM (2002) Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov 1:131–139
Tiwari SB, Amiji MM (2006) A review of nanocarrier based CNS delivery systems. Cur Drug Deliv 3:219–232
Xiang QY, Wang MT, Chen F, Gong T, Jian YL, Zhang ZR, Huang Y (2007) Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch Pharm Res 30:519–525
Kreuter J (2001) Nanoparticles system for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81
Petri B, Bootz A, Khalansky A, Hekmatara T, Müller R, Uhl R, Kreuter J, Gelperina S (2007) Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release 117:51–58
Iea B (2004) Negative preclinical results with stealth1 nanospheres encapsulated doxorubicin in an orthotopic murine brain tumor model. J Control Release 100:29–40
Allen DD, Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ (2003) Brain uptake of thiamine-coated nanoparticles. J Control Release 93:271–282
Thole M, Nobmanna S, Huwyler J, Bartmann A, Fricker GJ (2002) Uptake of cationized albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries. J Drug Target 10:337–344
Muller RH, Keck CM (2004) Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113:151–170
Kakkar V, Kaur IP (2012) Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 49:2906–2913
Kakkar V, Kaur IP (2012) Antidepressant activity of curcumin loaded solid lipid nanoparticles (C-SLNs) in mice. Am J PharmTech Res 2:729–736
Yassin AEB, Anwer MK, Mowafy HA, El-Bagory IM, Bayomi MA, Alsarra IA (2010) Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 7:398–408
Lu B, Xiong S-B, Yang H, Yin X-D, Chao R-B (2006) Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 28:86–95
Reddy JS, Venkateshwarlu V (2004) Novel delivery systems for drug targeting to the brain. Drugs Future 29:63–83
www.agius.com, http://www.agius.com/hew/resource/toxicol.htm. Accessed 5 May 2013
Zhao J, Castranova V (2011) Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev 14:593–632
Silva AC, González-Mira ME, Garcia ML, Egea MA, Fonseca J, Silva R (2011) Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces 86:158–165
Muller R, Ruhl D, Runge S, Sculze-Foster K, Mehenert W (1997) Cytotoxicity of solid lipid nanoparticles as a function of lipid matrix and the surfactant. Pharm Res 4:458–462
Weyhers H, Hahn WMH, Muller RH (1995) Solid lipid nanoparticles-determination of in vivo toxicity. First world meeting APGI/APV489-490
Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C (2007) Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 59:454–477
Charman WN, Porter CJH, Mithani S, Dressman JB (1997) Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 86:269–282
Liversidge GG, Cundy KC (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 125:91–97
Gasco MR (2007) Nanoparticulate drug delivery systems: gastrointestinal applications of nanoparticulate drug-delivery systems. Informa Healthcare, New York, pp 305–316
Hu L, Xing Q, Meng J, Shang C (2010) Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. AAPS PharmSciTech 11(2):582–587
Varshosaz J, Minayian M, Moazen E (2010) Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. J Liposome Res 20:115–123
Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58:2095–2099
Li HL, Zhao XB, Ma YK, Zhai GX, Li LB, Lou HX (2009) Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133:238–244
Luo Y, Chen D, Ren L, Zhao X, Qin J (2006) Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release 114:53–59
Müller RH, Runge S, Ravelli V, Mehnert W, Thünemann AF, Souto EB (2006) Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int J Pharm 317:82–89
Manjunath K, Venkateshwarlu V (2006) Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. J Drug Target 14:632–645
Wang JX, Sun X, Zhang ZR (2002) Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J Pharm Biopharm 54:285–290
Yang S, Zhu J, Lu Y, Liang B, Yang C (1999) Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 16:751–757
Pandey R, Sharma S, Khuller GK (2005) Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis 85:415–420
Xie S, Zhu L, Dong Z, Wang Y, Wang X, Zhou W (2011) Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles. Int J Nanomedicine 6:547–555
Huang L, Liu Y (2011) In vivo delivery of RNAi with lipid-based nanoparticles. Annu Rev Biomed Eng 13:507–530
Li W, Szoka FC (2007) Lipid based nanoparticles for nucleic acid delivery. Pharm Res 24:438–449
Mintzer MA, Simanek EE (2009) Nonviral vectors for gene delivery. Chem Rev 109:259–302
Nyunt MT, Dicus CW, Cui Y-Y, Yappert MC, Huser TR, Nantz MH, Wu J (2009) Physico-chemical characterization of polylipid nanoparticles for gene delivery to the liver. Bioconjug Chem 20:2047–2054
Fan Y, Wu J (2013) Polylipid nanoparticle, a novel lipid-based vector for liver gene transfer.Gene Therapy - Tools and Potential Applications. Francisco Martin Molina (Ed.). InTech
Jian LI, Ying-ZI HE, Wen LI, Shen Y-Z, Y-R LI, Wang Y-F (2010) A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin 31:509–514
Wang J, Ornek-Ballanco C, Xu J, Yang W, Yu X (2013) Preparation and characterization of vinculin-targeted polymer–lipid nanoparticle as intracellular delivery vehicle. Int J Nanomedicine 8:39–46
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kaur, I.P., Bhandari, R., Yakhmi, J.V. (2014). Lipids as Biological Materials for Nanoparticulate Delivery. In: Bhushan, B., Luo, D., Schricker, S., Sigmund, W., Zauscher, S. (eds) Handbook of Nanomaterials Properties. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31107-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-31107-9_27
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31106-2
Online ISBN: 978-3-642-31107-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)